| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |